Not yet recruitingPhase 3NCT07900633
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Sponsor: Eli Lilly and Company
Apache Junction, AZ · Gilbert, AZ · Phoenix, AZ · +67 more sites